The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 735-740 , July 2008

Prognostic Relationship Between Two Serial Determinations of B-type Natriuretic Peptide and Medium–Long-term Events in Heart Transplantation

  • Luis Martínez-Dolz, MD, PhD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain
    • Corresponding Author InformationReprint requests: Luis Martínez Dolz, MD, Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Cavanilles 26-11, 46010 Valencia, Spain. Telephone: 00-34-96-386-2759. Fax: 00-34-96-197-3314.
    • ,
  • Luis Almenar, MD, PhD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain
    • ,
  • Isabel Hervás, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, University Hospital La Fe, Valencia, Spain
    • ,
  • José Moro, MD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain
    • Foundation for Investigation, University Hospital La Fe, Valencia, Spain.
    • ,
  • Jaime Agüero, MD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain
    • ,
  • Ignacio Sánchez-Lázaro, MD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain
    • ,
  • Antonio Mateo, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, University Hospital La Fe, Valencia, Spain
    • ,
  • Antonio Salvador, MD, PhD

      Affiliations

    • Heart Failure and Transplant Unit, Department of Cardiology, University Hospital La Fe, Valencia, Spain

Received 21 October 2007 ,Revised 2 April 2008 ,Accepted 21 April 2008.

References 

  1. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?. J Am Coll Cardiol. 2004;44:740–749
  2. Osca J, Quesada A, Arnau MA, et al. Brain natriuretic peptide (Diagnostic value in heart failure). Rev Esp Cardiol. 2002;55:7–15
  3. Yu CM, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure (Higher ANP and BNP levels are associated with the restrictive filling pattern). Eur Heart J. 1996;17:1694–1702
  4. Lang CC, Prasad N, McAlpine HM, et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J. 1994;127:1635–1636
  5. Perna ER, Macin SM, Cimbaro Canella JP, et al. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. J Heart Lung Transplant. 2006;25:1230–1240
  6. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107:1278–1283
  7. Sirgurdsson A, Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J. 1996;132:229–234
  8. Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart. 1999;81:114–120
  9. de Lemos J, Morrow D, Bentley J, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  10. Sabatine M, Morrow D, de Lemos J, et al. Multimarker approach to risk stratification in non–ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760–1763
  11. Ishizaka Y, Yamamoto Y, Fukunaga T, et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis. 1994;24:461–472
  12. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma (Reference values in healthy subjects and in patients with different diseases). Scand J Clin Lab Invest. 1997;57:529–540
  13. Ationu A, Burch M, Singer D, Littleton P, Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res. 1993;27:188–191
  14. Geny B, Follenius M, Epailly E, et al. Transient reduction without normalization of brain natriuretic peptide early after heart transplantation. J Thorac Cardiovasc Surg. 1998;115:473–475
  15. Park MH, Scott RL, Uber PA, Mehra MR. Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant. 2002;21:613–614
  16. Arnau-Vives M, Almenar L, Hervas I, et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant. 2004;23:850–856
  17. Hammerer-Lercher A, Mair J, Antretter H, et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant. 2005;24:1444
  18. O'Neill JO, McRae AT, Troughton RW, et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant. 2005;24:416–420
  19. Mehra M, Uber P, Potluri S, et al. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol. 2004;94:454–458
  20. Park M, Scott R, Uber P, et al. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol. 2002;90:1326–1329
  21. Martínez-Dolz L, Almenar L, Moro J, et al. Prognostic value of BNP in heart transplant patients. J Heart Lung Transplant. 2007;26:986–991
  22. Shaw SM, Williams SG. Is brain natriuretic peptide clinically useful after cardiac transplantation?. J Heart Lung Transplant. 2006;25:1396–1401
  23. Almenar L, Martinez-Dolz L, Moro J. Natriuretic peptides and heart transplant. Curr Opin Mol Ther. 2007;9:282–290
  24. Gardner RS, Chong KS, Murday AJ, Morton JJ, McDonagh TA. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart. 2006;92:121–123
  25. Ambrosi P, Oddoze C, Riberi A, et al. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am J Cardiol. 2004;94:1585–1587
  26. Kirchhoff W, Gradaus R, Stypmann J, et al. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation. J Heart Lung Transplant. 2004;23:284–288
  27. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
  28. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trial. JAMA. 2003;289:730–740
  29. Sinha AM, Filzmaier K, Breithardt OA, et al. Usefulness of brain natriuretic release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol. 2003;91:755–758
  30. Buckley MG, Sethi D, Markandu ND, et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci. 1992;83:437–444
  31. El Gamel A, Yonan NA, Keevil B, et al. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg. 1997;63:1095–1100
  32. Burgess MI, Bhattacharyya A, Ray SG. Echocardiography after cardiac transplantation. J Am Soc Echocardiogr. 2002;15:917–925
  33. Mehra R, Uber P, Walther D, et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation (More than a hemodynamic marker). Circulation. 2006;114(suppl I):I-21–I-26
  34. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med. 2002;113:215–219
  35. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:2168–2174

PII: S1053-2498(08)00344-6

doi: 10.1016/j.healun.2008.04.008

The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 735-740 , July 2008

Article Tools

* Image Usage & Resolution